We were on the cusp of an EUA in June/July of 2020 and we've been suppressed ever since. The company that benefited the most was Gilead Sciences with remdesivir, ( May 2020 - CytoDyn to Prepare a Phase 3 Protocol to Submit to the FDA for a Three-Arm Comparative and Combination Trial of Leronlimab and Remdesivir), and the other company was Regeneron with REGN-Cov2.

I always felt weird about Gilead because first we were going to do a trial with them, then that is dropped, and Remdesivir is given an EUA and then later we discover our CD12 is being 'helped" by people with connections to Gilead.